A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Clinical trial NCT07475572 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07475572
- Sponsor
- Alvotech Swiss AG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-19
- Primary completion
- 2027-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.